{{Rsnum
|rsid=4082919
|Gene=PGS1
|Chromosome=17
|position=78381401
|Orientation=plus
|GMAF=0.4481
|Gene_s=PGS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 23.9 | 50.4 | 25.7
| HCB | 43.1 | 40.9 | 16.1
| JPT | 18.6 | 60.2 | 21.2
| YRI | 52.7 | 43.2 | 4.1
| ASW | 42.1 | 49.1 | 8.8
| CHB | 43.1 | 40.9 | 16.1
| CHD | 40.7 | 50.0 | 9.3
| GIH | 22.8 | 59.4 | 17.8
| LWK | 49.1 | 40.9 | 10.0
| MEX | 20.7 | 50.0 | 29.3
| MKK | 30.1 | 51.9 | 17.9
| TSI | 40.2 | 37.3 | 22.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23861364
|Title=Do Genetic Modifiers of HDL-C and Triglyceride Levels also Modify Their Response to a Lifestyle Intervention in the Setting of Obesity and Type-2 Diabetes Mellitus? The Look AHEAD Study
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}